Search Results - "Dronda, F."

Refine Results
  1. 1

    Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals by Vázquez-Castellanos, J F, Serrano-Villar, S, Latorre, A, Artacho, A, Ferrús, M L, Madrid, N, Vallejo, A, Sainz, T, Martínez-Botas, J, Ferrando-Martínez, S, Vera, M, Dronda, F, Leal, M, Del Romero, J, Moreno, S, Estrada, V, Gosalbes, M J, Moya, A

    Published in Mucosal immunology (01-07-2015)
    “…Altered interplay between gut mucosa and microbiota during treated HIV infection may possibly contribute to increased bacterial translocation and chronic…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Inequalities in HIV disease management and progression in migrants from Latin America and sub‐Saharan Africa living in Spain by Monge, S, Alejos, B, Dronda, F, Del Romero, J, Iribarren, JA, Pulido, F, Rubio, R, Miró, JM, Gutierrez, F, Del Amo, J

    Published in HIV medicine (01-05-2013)
    “…Objectives The objective of the study was to analyse key HIV‐related outcomes in migrants originating from Latin America and the Spanish‐speaking Caribbean…”
    Get full text
    Journal Article
  4. 4

    Decreasing prevalence of HCV coinfection in all risk groups for HIV infection between 2004 and 2011 in Spain by Serrano-Villar, S., Sobrino-Vegas, P., Monge, S., Dronda, F., Hernando, A., Montero, M., Viciana, P., Clotet, B., Pineda, J. A., del Amo, J., Moreno, S.

    Published in Journal of viral hepatitis (01-05-2015)
    “…Summary While hepatitis C virus (HCV) infection seems to be expanding among HIV‐infected men who have sex with men (MSM), the rate of coinfection in…”
    Get full text
    Journal Article
  5. 5

    High levels of CD4+ CTLA-4+ Treg cells and CCR5 density in HIV-1-infected patients with visceral leishmaniasis by Vallejo, A., Abad-Fernández, M., Moreno, S., Moreno, A., Pérez-Elías, M. J., Dronda, F., Casado, J. L.

    “…Visceral leishmaniasis (VL) in HIV-1-infected patients has been associated with poor immunological recovery and frequent disease relapses. The aim of this…”
    Get full text
    Journal Article
  6. 6

    Development of tuberculosis in human immunodeficiency virus infected patients receiving antiretroviral therapy by Martín-Echevarria, E., Serrano-Villar, S., Sainz, T., Moreno, A., Casado, J. L., Dronda, F., Elías, M. J. Pérez, Navas, E., Zapata, M. Rodríguez, Moreno, S.

    “…BACKGROUND: It is unclear whether optimal immunological recovery reduces the risk of tuberculosis (TB) in human immunodeficiency virus (HIV) infected patients…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Peliosis hepatis due to disseminated tuberculosis in a patient with AIDS by Sanz-Canalejas, L., Gómez-Mampaso, E., Cantón-Moreno, R., Varona-Crespo, C., Fortún, J., Dronda, F.

    Published in Infection (01-02-2014)
    “…Peliosis hepatis is a rare histopathological entity of unknown etiology. We present a case of peliosis hepatis in a 44-year-old man with disseminated…”
    Get full text
    Journal Article
  9. 9

    Incidence of tuberculosis in HIV-infected patients receiving HAART: interaction between TST and CD4 count by MARTIN-ECHEVARRIA, E, RODRIGUEZ-ZAPATA, M, TORRALBA, M, FERNANDEZ, J. M. R, MORENO, A, CASADO, J. L, DRONDA, F, PEREZ-ELIAS, M. J, NAVAS, E, MORENO, S

    “…BACKGROUND: There may be an interaction between the CD4 count and the tuberculin skin test (TST) for the development of tuberculosis (TB) in human immunode…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Usefulness of the secondary probe pTBN12 in DNA fingerprinting of Mycobacterium tuberculosis by CHAVES, F, ZHENHUA YANG, HIYAM EL HAJJ, ALONSO, M, BURMAN, W. J, EISENACH, K. D, DRONDA, F, BATES, J. H, CAVE, M. D

    Published in Journal of Clinical Microbiology (01-05-1996)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  12. 12

    Effect of food on the antiviral activity of didanosine enteric‐coated capsules: a pilot comparative study by Hernández‐Novoa, B, Antela, A, Gutiérrez, C, Pérez‐Molina, JA, Pérez‐Elías, MJ, Dronda, F, Moreno, A, Casado, JL, Page, C, Pumares, M, Galán, JC, Moreno, S

    Published in HIV medicine (01-04-2008)
    “…Objectives To determine the effect of food on the antiviral activity of enteric‐coated (EC) capsules of didanosine (ddI). Methods We conducted a pilot,…”
    Get full text
    Journal Article
  13. 13

    Risk Factors for Development of Tuberculosis after Isoniazid Chemoprophylaxis in Human Immunodeficiency Virus—Infected Patients by Casado, José L., Moreno, Santiago, Fortún, Jesús, Antela, Antonio, Quereda, Carmen, Navas, Enrique, Moreno, Ana, Dronda, Fernando

    Published in Clinical infectious diseases (01-02-2002)
    “…The long-term benefit of isoniazid chemoprophylaxis in human immunodeficiency virus (HIV)–infected patients and risk factors for isoniazid failure were studied…”
    Get full text
    Journal Article
  14. 14

    Mixed oropharyngeal candidiasis due to Candida albicans and non-albicans Candida strains in HIV-infected patients by DRONDA, F, ALONSO-SANZ, M, LAGUNA, F, CHAVES, F, MARTINEZ-SUAREZ, J. V, RODRIGUEZ-TUDELA, J. L, GONZALEZ-LOPEZ, A, VALENCIA, E

    “…In order to determine the clinical significance of mixed oropharyngeal candidiasis (Candida albicans plus a non-albicans strain of Candida) in patients…”
    Get full text
    Journal Article
  15. 15

    Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study by Judd, Ali, Zangerle, Robert, Touloumi, Giota, Warszawski, Josiane, Meyer, Laurence, Dabis, François, Mary Krause, Murielle, Ghosn, Jade, Leport, Catherine, Wittkop, Linda, Reiss, Peter, Wit, Ferdinand, Prins, Maria, Bucher, Heiner, Gibb, Diana, Fätkenheuer, Gerd, Julia, Del Amo, Obel, Niels, Thorne, Claire, Mocroft, Amanda, Kirk, Ole, Stephan, Christoph, Pérez-Hoyos, Santiago, Hamouda, Osamah, Bartmeyer, Barbara, Chkhartishvili, Nikoloz, Noguera-Julian, Antoni, Antinori, Andrea, d’Arminio Monforte, Antonella, Brockmeyer, Norbert, Prieto, Luis, Rojo Conejo, Pablo, Soriano-Arandes, Antoni, Battegay, Manuel, Kouyos, Roger, Mussini, Cristina, Tookey, Pat, Casabona, Jordi, Miró, Jose M, Castagna, Antonella, Konopnick, Deborah, Goetghebuer, Tessa, Sönnerborg, Anders, Quiros-Roldan, Eugenia, Sabin, Caroline, Teira, Ramon, Garrido, Myriam, Haerry, David, de Wit, Stéphane, Costagliola, Dominique, d’Arminio-Monforte, Antonella, del Amo, Julia, Raben, Dorthe, Chêne, Geneviève, Pablo Rojo, Conejo, Barger, Diana, Schwimmer, Christine, Termote, Monique, Campbell, Maria, Frederiksen, Casper M, Friis-Møller, Nina, Kjaer, Jesper, Salbøl Brandt, Rikke, Berenguer, Juan, Bohlius, Julia, Bouteloup, Vincent, Cozzi-Lepri, Alessandro, Davies, Mary-Anne, Dorrucci, Maria, Dunn, David, Egger, Matthias, Furrer, Hansjakob, Grabar, Sophie, Guiguet, Marguerite, Lambotte, Olivier, Leroy, Valériane, Lodi, Sara, Matheron, Sophie, Miro, Jose M, Monge, Susana, Nakagawa, Fumiyo, Paredes, Roger, Phillips, Andrew, Puoti, Massimo, Rohner, Eliane, Schomaker, Michael, Smit, Colette, Sterne, Jonathan, Thiebaut, Rodolphe, Torti, Carlo, van der Valk, Marc, Tanser, Frank, Vinikoor, Michael, Macete, Eusebio, Wood, Robin, Stinson, Kathryn, Garone, Daniela, Fatti, Geoffrey, Giddy, Janet, Malisita, Kennedy

    Published in Clinical infectious diseases (15-10-2017)
    “…Background. We compared Kaposi sarcoma (KS) risk in adults who started antiretroviral therapy (ART) across the Asia-Pacific, South Africa, Europe, Latin, and…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Efficacy, tolerance, and pharmacokinetics of the combination of stavudine, nevirapine, nelfinavir, and saquinavir as salvage regimen after ritonavir or indinavir failure by Casado, J L, Dronda, F, Hertogs, K, Sabido, R, Antela, A, Martí-Belda, P, Dehertogh, P, Moreno, S

    Published in AIDS research and human retroviruses (20-01-2001)
    “…The high rate of protease inhibitor treatment failure in clinical cohorts makes it necessary to define novel salvage therapies. In a prospective study of 31…”
    Get more information
    Journal Article
  18. 18

    Effectiveness and pitfalls of initial highly active antiretroviral therapy in HIV-infected patients in routine clinical practice by Moreno, A, Perez-Elías, M J, Casado, J L, Muñoz, V, Antela, A, Dronda, F, Navas, E, Fortún, J, Quereda, C, Moreno, S

    Published in Antiviral therapy (01-12-2000)
    “…To assess the long-term effectiveness of and factors associated with response to protease inhibitors (PIs) in a cohort of treatment-naive HIV-infected…”
    Get full text
    Journal Article
  19. 19

    Phenotypic cross-resistance to nelfinavir: the role of prior antiretroviral therapy and the number of mutations in the protease gene by Dronda, F, Casado, J L, Moreno, S, Hertogs, K, García-Arata, I, Antela, A, Pérez-Elías, M J, Ruiz, L, Larder, B

    Published in AIDS research and human retroviruses (10-02-2001)
    “…Cross-resistance to nelfinavir (NFV) is observed in patients failing protease inhibitor (PI)-containing therapies. We performed a study with 111 patients who…”
    Get more information
    Journal Article
  20. 20

    Predicting tuberculosis among HIV-infected patients admitted to hospital: Comparison of a model with clinical judgment of infectious disease specialists by COBO, J, OLIVA, J, ASENSIO, A, NAVAS, E, COBO, M. E, SANCHEZ-GARCIA, M. D, DRONDA, F, GOMEZ-MAMPASO, E, GUERRERO, A, MORENO, S

    “…The aim of this prospective study was to compare a model based on clinical variables with the clinical judgment of infectious disease specialists to identify…”
    Get full text
    Journal Article